Company registration number 07795200 (England and Wales)
SCION MEDICA LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
SCION MEDICA LIMITED
COMPANY INFORMATION
Director
G E Peterson
Company number
07795200
Registered office
Mere House
Brook Street
Knutsford
Cheshire
WA16 8GP
Auditor
Azets Audit Services
Ship Canal House
98 King Street
Manchester
M2 4WU
SCION MEDICA LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
SCION MEDICA LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
3
12,132,973
9,573,462
Cash at bank and in hand
444,079
206,169
12,577,052
9,779,631
Creditors: amounts falling due within one year
4
(4,521,338)
(3,395,556)
Net current assets
8,055,714
6,384,075
Capital and reserves
Called up share capital
5
100
100
Profit and loss reserves
8,055,614
6,383,975
Total equity
8,055,714
6,384,075

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 30 April 2026
G E Peterson
Director
Company registration number 07795200 (England and Wales)
SCION MEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

Scion Medica Limited is a private company limited by shares incorporated in England and Wales. The registered office is Mere House, Brook Street, Knutsford, Cheshire, WA16 8GP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he director continues to adopt the going concern basis of accounting in preparing the financial statements.

I n forming this assessment, the director has a reasonable expectation of continued support through the injection of funds to the wider group, if required, from external investors and is confident the underlying business has the ability to generate sufficient positive cash flows which will support the payment of liabilities and meet all other financial obligations as they fall due. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

The director note s that the business is trading profitably in terms of Earnings Before Interest, Tax, Depreciation and Amortisation and is forecast to continue to be cash generative for a period of at least 12 months from the date of signing these accounts.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and trade discounts.

Profit on long-term contracts is recognised as the work is carried out if the final outcome can be assessed with reasonable certainty. The profit included is calculated on a prudent basis to reflect the proportion of the work carried out at the year end, by recording turnover and related costs as contract activity progresses. Turnover is calculated as that proportion of total contract value which costs incurred to date bear to total expected costs for that contract. Revenues derived from variations on contracts are recognised only when they have been accepted by the customer.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

SCION MEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price. Financial assets classified as receivable within one year are not amortised.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

SCION MEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are enacted or substantively enacted at the balance sheet date. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.8
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The company has no employees, all staff are employed by a fellow group company, Prime Medica Limited, and an appropriate recharge is made for the time spent by those individuals working for this company.

3
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
1,818,035
1,897,855
Corporation tax recoverable
-
0
112,829
Amounts owed by group undertakings
10,106,261
7,215,179
Other debtors
43,446
12,248
Prepayments and accrued income
165,231
335,351
12,132,973
9,573,462

Amounts owed by group undertakings are interest free and repayable on demand.

Included in prepayments and accrued income is an amount relating to accrued income of £165,231 (2024: £335,351).

Included in amounts owed by fellow group undertakings is a liability relating to group relief on corporation tax of £754,727 (2024: £197,514 included in amounts owed to group undertakings).

SCION MEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
4
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
107,651
64,185
Amounts owed to group undertakings
3,501,625
2,332,188
Corporation tax
8,122
-
0
Accruals and deferred income
903,940
999,183
4,521,338
3,395,556

Amounts owed to group undertakings are interest free and repayable on demand.

Included in accruals and deferred income is an amount relating to deferred income of £797,994 (2024: £849,618).

5
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
of £1 each
100
100
100
100

The company has one class of ordinary shares. There are no restrictions on the distribution of dividends and repayment of capital. The holders of ordinary shares are entitled to receive dividends as declared and are entitled to one vote per share at meetings of the company.

6
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

- give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Senior Statutory Auditor:
Andrew Reddington
Statutory Auditor:
Azets Audit Services
Date of audit report:
30 April 2026
SCION MEDICA LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
7
Financial commitments, guarantees and contingent liabilities

The company's present and future assets are subject to a fixed and floating charge in favour of GLAS Trust Corporation Limited in respect of certain borrowings of a fellow group company, Moonbeam Bidco Ltd. At 31 December 202 5, the net borrowings encompassed by the charges amounted to £56,011,221 (2024: £52,855,834).

8
Related party transactions

The company has taken advantage of the available exemption under FRS 102 paragraph 33.1A not to disclose transactions with wholly owned members of the group.

9
Parent company

The company's immediate parent undertaking is Prime Global Medical Communications Ltd, a company incorporated in England and Wales and registered at Mere House, Brook Street, Knutsford, Cheshire, WA16 8GP. The results of this company are included in the consolidated accounts of Prime Global Medical Communications Ltd.

The largest group in which this company's results are consolidated is that headed by Moonbeam Topco Ltd. The consolidated accounts are available from Companies house, Crown Way, Cardiff, CF14 3UZ.

The company's ultimate parent undertaking and controlling party is considered to be Levine Leichtman Capital Partners Europe II SCSP Sarl, a company registered in Luxembourg.

2025-12-31 2025-01-01 false false false 30 April 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity G E Peterson 07795200 2025-01-01 2025-12-31 07795200 bus:Director1 2025-01-01 2025-12-31 07795200 bus:RegisteredOffice 2025-01-01 2025-12-31 07795200 2025-12-31 07795200 2024-12-31 07795200 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 07795200 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 07795200 core:WithinOneYear 2025-12-31 07795200 core:WithinOneYear 2024-12-31 07795200 core:ShareCapital 2025-12-31 07795200 core:ShareCapital 2024-12-31 07795200 core:RetainedEarningsAccumulatedLosses 2025-12-31 07795200 core:RetainedEarningsAccumulatedLosses 2024-12-31 07795200 core:ShareCapitalOrdinaryShareClass1 2025-12-31 07795200 core:ShareCapitalOrdinaryShareClass1 2024-12-31 07795200 core:CurrentFinancialInstruments 2025-12-31 07795200 core:CurrentFinancialInstruments 2024-12-31 07795200 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 07795200 bus:OrdinaryShareClass1 2025-12-31 07795200 bus:OrdinaryShareClass1 2024-12-31 07795200 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 07795200 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 07795200 bus:FRS102 2025-01-01 2025-12-31 07795200 bus:Audited 2025-01-01 2025-12-31 07795200 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP